Investors may want to consider boosting their exposure abroad —...
Home bias in the U.S. is at a peak, with investors heavily concentrated in domestic markets.
Home bias in the U.S. is at a peak, with investors heavily concentrated in domestic markets.
AstraZeneca delists ADRs from Nasdaq for NYSE ordinary shares, attracting new U.S. investors.